The Idd3/10/18 strain demonstrates a median protection against anti PDL1 accelerated diabetes development with a 31% cumulative incidence as opposed to a cumulative incidence of 94% in Idd10/18, and 0% in the Idd3/5 strain following treatment. The gene discussed is CD274; the disease is diabetes mellitus.